View More View Less
  • 1 Szegedi Tudományegyetem, Szent-Györgyi Albert Klinikai Központ, Általános Orvostudományi Kar I. Belgyógyászati Klinika Szeged Korányi fasor 8–10. 6720
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A protonpumpagátlók alkalmazása elterjedt a gyomorsav okozta megbetegedések kezelésében, mivel ezek a szerek meglehetősen hatékonyak és biztonságosan alkalmazhatóak. Alkalmazásuk viszont az elmúlt 10 évben több mint háromszorosára nőtt, ami egyértelműen nincs arányban a savval összefüggő kórképek növekedésével. Ez különösképpen azért is aggályos, mert a legtöbb gyógyszernek – csakúgy, mint ezeknek a szereknek is – vannak mellékhatásaik. Az utóbbi években több tanulmány is megjelent, melyekben a hosszú távú protonpumpagátló kezelés és a csonttörések gyakoriságának növekedése közötti összefüggést vizsgálták. A tanulmányok többségében kimutatták, hogy a hosszú távú protonpumpagátló kezelés kismértékben növeli a csonttörések kockázatát. A gyakoribb törések hátterében álló mechanizmusok nem tisztázottak kellőképpen, azonban valószínűleg a terápia hatására kialakuló krónikus hypoaciditas játszik benne szerepet, mely befolyásolja a kalcium és a B12-vitamin felszívódását, illetve közvetetten befolyásolja a csontrendszert is, csökkentve a csontsűrűséget. A rendelkezésre álló adatok alapján mindenképpen ajánlott az óvatosság protonpumpagátló kezelés indítása esetén olyan betegek körében, akiknél fokozott az osteoporosis kialakulásának kockázata. Orv. Hetil., 2013, 154, 1005–1009.

  • Forgacs, I., Loganayagam, A.: Overprescribing proton pump inhibitors. BMJ, 2008, 336, 2–3.

    Loganayagam A. , 'Overprescribing proton pump inhibitors ' (2008 ) 336 BMJ : 2 -3.

  • Leontiadis, G. I., Sreedharan, A., Dorward, S., et al.: Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. Health Technol. Assess., 2007, 11, iii–iv, 1–164.

    Dorward S. , 'Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding ' (2007 ) 11 Health Technol. Assess. : iii -iv, 1–164.

    • Search Google Scholar
  • Patel, V., Fordtran, J. S.: Hazards of PPI overuse and possible ways to curtail it. Nat. Clin. Pract. Gastroenterol. Hepatol., 2007, 4, 246–247.

    Fordtran J. S. , 'Hazards of PPI overuse and possible ways to curtail it ' (2007 ) 4 Nat. Clin. Pract. Gastroenterol. Hepatol. : 246 -247.

    • Search Google Scholar
  • Heidelbaugh, J. J., Goldberg, K. L., Inadomi, J. M.: Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am. J. Gastroenterol., 2009, 104 (Suppl. 2), S27–S32.

    Inadomi J. M. , 'Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected] ' (2009 ) 104 Am. J. Gastroenterol. : S27 -S32.

    • Search Google Scholar
  • Pham, C. Q., Regal, R. E., Bostwick, T. R., et al.: Acid suppressive therapy use on an inpatient internal medicine service. Ann. Pharmacother., 2006, 40, 1261–1266.

    Bostwick T. R. , 'Acid suppressive therapy use on an inpatient internal medicine service ' (2006 ) 40 Ann. Pharmacother. : 1261 -1266.

    • Search Google Scholar
  • Pap, A.: Adverse effect of long-term proton pump inhibitor therapy. [A hosszú távú protonpumpagátló kezelés mellékhatásai.] LAM, 2009, 19, 489–492. [Hungarian]

    Pap A. , 'Adverse effect of long-term proton pump inhibitor therapy. [A hosszú távú protonpumpagátló kezelés mellékhatásai.] ' (2009 ) 19 LAM : 489 -492.

    • Search Google Scholar
  • Yang, Y. X., Metz, D. C.: Safety of proton pump inhibitor exposure. Gastroenterology, 2010, 139, 1115–1127.

    Metz D. C. , 'Safety of proton pump inhibitor exposure ' (2010 ) 139 Gastroenterology : 1115 -1127.

    • Search Google Scholar
  • Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., et al.: Gastrointestinal absorption of calcium from milk and calcium salts. N. Eng. J. Med., 1987, 317, 532–536.

    Nicar M. J. , 'Gastrointestinal absorption of calcium from milk and calcium salts ' (1987 ) 317 N. Eng. J. Med. : 532 -536.

    • Search Google Scholar
  • Recker, R. R.: Calcium absorption and achlorhydria. N. Engl. J. Med., 1985, 313, 70–73.

    Recker R. R. , 'Calcium absorption and achlorhydria ' (1985 ) 313 N. Engl. J. Med. : 70 -73.

  • Chonan, O., Takahashi, R., Yasui, H., et al.: Effect of L-lactic acid on calcium absorption in rats fed omeprazole. J. Nutr. Sci. Vitaminol. (Tokyo), 1998, 44, 473–481.

    Yasui H. , 'Effect of L-lactic acid on calcium absorption in rats fed omeprazole ' (1998 ) 44 J. Nutr. Sci. Vitaminol. (Tokyo) : 473 -481.

    • Search Google Scholar
  • Merriman, N. A., Putt, M. E., Metz, D. C., et al.: Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology, 2010, 138, 1330–1337.

    Metz D. C. , 'Hip fracture risk in patients with a diagnosis of pernicious anemia ' (2010 ) 138 Gastroenterology : 1330 -1337.

    • Search Google Scholar
  • Goerss, J. B., Kim, C. H., Atkinson, E. J., et al.: Risk of fractures in patients with pernicious anemia. J. Bone Miner. Res., 1992, 7, 573–579.

    Atkinson E. J. , 'Risk of fractures in patients with pernicious anemia ' (1992 ) 7 J. Bone Miner. Res. : 573 -579.

    • Search Google Scholar
  • Nilas, L., Christiansen, C., Christiansen, J.: Regulation of vitamin D and calcium metabolism after gastrectomy. Gut, 1985, 26, 252–257.

    Christiansen J. , 'Regulation of vitamin D and calcium metabolism after gastrectomy ' (1985 ) 26 Gut : 252 -257.

    • Search Google Scholar
  • Graziani, G., Badalamenti, S., Como, G., et al.: Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion. Nephron, 2002, 91, 474–479.

    Como G. , 'Calcium and phosphate plasma levels in dialysis patients after dietary Ca-P overload. Role of gastric acid secretion ' (2002 ) 91 Nephron : 474 -479.

    • Search Google Scholar
  • Hardy, P., Sechet, A., Hottelart, C., et al.: Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. Artif. Organs, 1998, 22, 569–573.

    Hottelart C. , 'Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis ' (1998 ) 22 Artif. Organs : 569 -573.

    • Search Google Scholar
  • O’Connell, M. B., Madden, D. M., Murray, A. M., et al.: Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am. J. Med., 2005, 118, 778–781.

    Murray A. M. , 'Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial ' (2005 ) 118 Am. J. Med. : 778 -781.

    • Search Google Scholar
  • Serfaty-Lacrosniere, C., Wood, R. J., Voytko, D., et al.: Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J. Am. Coll. Nutr., 1995, 14, 364–368.

    Voytko D. , 'Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans ' (1995 ) 14 J. Am. Coll. Nutr. : 364 -368.

    • Search Google Scholar
  • Hansen, K. E., Jones, A. N., Lindstrom, M. J., et al.: Do proton pump inhibitors decrease calcium absorption? J. Bone Miner. Res., 2010, 25, 2786–2795.

    Lindstrom M. J. , 'Do proton pump inhibitors decrease calcium absorption? ' (2010 ) 25 J. Bone Miner. Res. : 2786 -2795.

    • Search Google Scholar
  • Heaney, R. P.: Factors influencing the measurement of bioavailability, taking calcium as a model. J. Nutr., 2001, 131 (Suppl. 4), 1344S–1348S.

    Heaney R. P. , 'Factors influencing the measurement of bioavailability, taking calcium as a model ' (2001 ) 131 J. Nutr. : 1344S -1348S.

    • Search Google Scholar
  • Saltzman, J. R., Kemp, J. A., Golner, B. B., et al.: Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J. Am. Coll. Nutr., 1994, 13, 584–591.

    Golner B. B. , 'Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption ' (1994 ) 13 J. Am. Coll. Nutr. : 584 -591.

    • Search Google Scholar
  • Doscherholmen, A., Swaim, W. R.: Impaired assimilation of egg Co 57 vitamin B 12 in patients with hypochlorhydria and achlorhydria and after gastric resection. Gastroenterology, 1973, 64, 913–919.

    Swaim W. R. , 'Impaired assimilation of egg Co 57 vitamin B 12 in patients with hypochlorhydria and achlorhydria and after gastric resection ' (1973 ) 64 Gastroenterology : 913 -919.

    • Search Google Scholar
  • Festen, H. P.: Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand. J. Gastroenterol. Suppl., 1991, 188, 1–7.

    Festen H. P. , 'Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract ' (1991 ) 188 Scand. J. Gastroenterol. Suppl. : 1 -7.

    • Search Google Scholar
  • Thorens, J., Froehlich, F., Schwizer, W., et al.: Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut, 1996, 39, 54–59.

    Schwizer W. , 'Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study ' (1996 ) 39 Gut : 54 -59.

    • Search Google Scholar
  • Suter, P. M., Golner, B. B., Goldin, B. R., et al.: Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology, 1991, 101, 1039–1045.

    Goldin B. R. , 'Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis ' (1991 ) 101 Gastroenterology : 1039 -1045.

    • Search Google Scholar
  • Valuck, R. J., Ruscin, J. M.: A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J. Clin. Epidemiol., 2004, 57, 422–428.

    Ruscin J. M. , 'A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults ' (2004 ) 57 J. Clin. Epidemiol. : 422 -428.

    • Search Google Scholar
  • Termanini, B., Gibril, F., Sutliff, V. E., et al.: Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am. J. Med., 1998, 104, 422–430.

    Sutliff V. E. , 'Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome ' (1998 ) 104 Am. J. Med. : 422 -430.

    • Search Google Scholar
  • den Elzen, W. P., Groeneveld, Y., de Ruijter, W., et al.: Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment. Pharmacol. Ther., 2008, 27, 491–497.

    Ruijter W. , 'Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals ' (2008 ) 27 Aliment. Pharmacol. Ther. : 491 -497.

    • Search Google Scholar
  • Dhonukshe-Rutten, R. A., Lips, M., de Jong, N., et al.: Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J. Nutr., 2003, 133, 801–807.

    Jong N. , 'Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men ' (2003 ) 133 J. Nutr. : 801 -807.

    • Search Google Scholar
  • Lubec, B., Fang-Kircher, S., Lubec, T., et al.: Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim. Biophys. Acta, 1996, 1315, 159–162.

    Lubec T. , 'Evidence for McKusick’s hypothesis of deficient collagen cross-linking in patients with homocystinuria ' (1996 ) 1315 Biochim. Biophys. Acta : 159 -162.

    • Search Google Scholar
  • McLean, R. R., Jacques, P. F., Selhub, J. et al.: Homocysteine as a predictive factor for hip fracture in older persons. N. Engl. J. Med., 2004, 350, 2042–2049.

    Selhub J. , 'Homocysteine as a predictive factor for hip fracture in older persons ' (2004 ) 350 N. Engl. J. Med. : 2042 -2049.

    • Search Google Scholar
  • Metz, D. C., Vakily, M., Dixit, T. et al.: Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy. Aliment. Pharmacol. Ther., 2009, 29, 928–937.

    Dixit T. , 'Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy ' (2009 ) 29 Aliment. Pharmacol. Ther. : 928 -937.

    • Search Google Scholar
  • Gagnemo-Persson, R., Håkanson, R., Sundler, F., et al.: Growth of the parathyroid glands in omeprazole-treated chickens. Scand. J. Gastroenterol., 1994, 29, 493–497.

    Sundler F. , 'Growth of the parathyroid glands in omeprazole-treated chickens ' (1994 ) 29 Scand. J. Gastroenterol. : 493 -497.

    • Search Google Scholar
  • Fossmark, R., Stunes, A. K., Petzold, C., et al.: Decreased bone mineral density and reduced bone quality in H(+)/K(+) ATPase beta-subunit deficient mice. J. Cell. Biochem., 2012, 113, 141–147.

    Petzold C. , 'Decreased bone mineral density and reduced bone quality in H(+)/K(+) ATPase beta-subunit deficient mice ' (2012 ) 113 J. Cell. Biochem. : 141 -147.

    • Search Google Scholar
  • Khalili, H., Huang, E. S., Jacobson, B. C., et al.: Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ, 2012, 344, e372.

    Jacobson B. C. , 'Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study ' (2012 ) 344 BMJ : e372 -.

    • Search Google Scholar
  • Ozdil, K., Kahraman, R., Sahin, A., et al.: Bone density in proton pump inhibitors users: a prospective study.; Rheumatol. Int., 2013 Mar 2. [Epub ahead of print] PMID 23455632

  • Fraser, L. A., Leslie, W. D., Targownik, L. E., et al.: The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos. Int., 2013, 24, 1161–1168. [Epub 2012 Aug 14.]

    Targownik L. E. , 'The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study ' (2013 ) 24 Osteoporos. Int. : 1161 -1168.

    • Search Google Scholar
  • Mello, M., Weideman, R. A., Little, B. B., et al.: Proton pump inhibitors increase the incidence of bone fractures in hepatitis C patients. Dig. Dis. Sci., 2012, 57, 2416–2422.

    Little B. B. , 'Proton pump inhibitors increase the incidence of bone fractures in hepatitis C patients ' (2012 ) 57 Dig. Dis. Sci. : 2416 -2422.

    • Search Google Scholar
  • Yu, E. W., Bauer, S. R., Bain, P. A., et al.: Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am. J. Med., 2011, 124, 519–526.

    Bain P. A. , 'Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies ' (2011 ) 124 Am. J. Med. : 519 -526.

    • Search Google Scholar
  • Histing, T., Stenger, D., Scheuer, C., et al.: Pantoprazole, a proton pump inhibitor, delays fracture healing in mice. Calcif. Tissue Int., 2012, 90, 507–514.

    Scheuer C. , 'Pantoprazole, a proton pump inhibitor, delays fracture healing in mice ' (2012 ) 90 Calcif. Tissue Int. : 507 -514.

    • Search Google Scholar
  • Joo, M. K., Park, J. J., Lee, B. J., et al.: The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. Mol. Med. Rep., 2013, 7, 1267–1272.

    Lee B. J. , 'The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats ' (2013 ) 7 Mol. Med. Rep. : 1267 -1272.

    • Search Google Scholar